Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	Study Results


	Related Studies

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

This study has been terminated.

( Due to slow accrual )

Study NCT01100658 Information provided by Masonic Cancer Center, University of Minnesota

First Received on April 7, 2010. Last Updated on November 6, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Acute Disease
Brain Neoplasms
Leukemia
Leukemia, Lymphoid
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma

More general conditions related to this trial

Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Disease Attributes
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Nervous System Diseases
Nervous System Neoplasms
Pathologic Processes

Interventions listed in this trial

Methylphenidate
Placebo

More general drug interventions related to this trial

Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses

Sponsors listed in this trial

Masonic Cancer Center, University of Minnesota
Children's Cancer Research Fund

Back to top of Main Content